Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01952548 · ClinicalTrials.gov registry record · Phase 1

Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers

A Phase 1 study, sponsored by Kowa Research Institute.

Completed
Registry status
Phase 1
Development phase

NCT01952548 is a Phase 1 study that has completed, run by Kowa Research Institute.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01952548, a Phase 1 study, has completed, sponsored by Kowa Research Institute.

COMPLETED
Registry status
Phase 1
Development phase

Study Summary

This study will test single doses of the study drug in increasing amounts to see if it is safe.

Interventions

  • DRUG Placebo
  • DRUG K-312

Trial Details

FieldValue
Start Date 2013-05
Phase Phase 1

Sponsor

Kowa Research Institute

44 total trials

What the Registry Record Tells You About NCT01952548

The ClinicalTrials.gov registry entry for NCT01952548 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT01952548 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01952548 about?

NCT01952548 is a clinical study titled "Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers". This study will test single doses of the study drug in increasing amounts to see if it is safe.

What is the current status of trial NCT01952548?

This trial is currently completed. It is a Phase 1 study. The study started on 2013-05.

What interventions are being tested in trial NCT01952548?

The interventions under investigation include: Placebo (DRUG), K-312 (DRUG).

Who is sponsoring clinical trial NCT01952548?

This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.